Literature DB >> 27586703

Review of the quality of total mesorectal excision does not improve the prediction of outcome.

P Demetter1, A Jouret-Mourin2, G Silversmit3, T Vandendael3, C Sempoux2, A Hoorens4, N Nagy5, C Cuvelier6, N Van Damme3, F Penninckx7.   

Abstract

AIM: A fair to moderate concordance in grading of the total mesorectal excision (TME) surgical specimen by local pathologists and a central review panel has been observed in the PROCARE (Project on Cancer of the Rectum) project. The aim of the present study was to evaluate the difference, if any, in the accuracy of predicting the oncological outcome through TME grading by local pathologists or by the review panel.
METHOD: The quality of the TME specimen was reviewed for 482 surgical specimens registered on a prospective database between 2006 and 2011. Patients with a Stage IV tumour, with unknown incidence date or without follow-up information were excluded, resulting in a study population of 383 patients. Quality assessment of the specimen was based on three grades including mesorectal resection (MRR), intramesorectal resection (IMR) and muscularis propria resection (MPR). Using univariable Cox regression models, local and review panel histopathological gradings of the quality of TME were assessed as predictors of local recurrence, distant metastasis and disease-free and overall survival. Differences in the predictions between local and review grading were determined.
RESULTS: Resection planes were concordant in 215 (56.1%) specimens. Downgrading from MRR to MPR was noted in 23 (6.0%). There were no significant differences in the prediction error between the two models; local and central review TME grading predicted the outcome equally well.
CONCLUSION: Any difference in grading of the TME specimen between local histopathologists and the review panel had no significant impact on the prediction of oncological outcome for this patient cohort. Grading of the quality of TME as reported by local histopathologists can therefore be used for outcome analysis. Quality control of TME grading is not warranted provided the histopathologist is adequately trained. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Total mesorectal excision; adenocarcinoma; oncological outcome; rectum

Mesh:

Year:  2016        PMID: 27586703     DOI: 10.1111/codi.13254

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  3 in total

1.  Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.

Authors:  Julia Kitz; Emmanouil Fokas; Tim Beissbarth; Philipp Ströbel; Christian Wittekind; Arndt Hartmann; Josef Rüschoff; Thomas Papadopoulos; Elisabeth Rösler; Peter Ortloff-Kittredge; Ulrich Kania; Hans Schlitt; Karl-Heinrich Link; Wolf Bechstein; Hans-Rudolf Raab; Ludger Staib; Christoph-Thomas Germer; Torsten Liersch; Rolf Sauer; Claus Rödel; Michael Ghadimi; Werner Hohenberger
Journal:  JAMA Surg       Date:  2018-08-15       Impact factor: 14.766

Review 2.  Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread.

Authors:  A A J Grüter; A S van Lieshout; S E van Oostendorp; J C F Ket; M Tenhagen; F C den Boer; R Hompes; P J Tanis; J B Tuynman
Journal:  Tech Coloproctol       Date:  2022-08-29       Impact factor: 3.699

3.  Uptake of Total Mesorectal Excision and Total Mesorectal Excision Grading for Rectal Cancer: A Statewide Study.

Authors:  Arielle E Kanters; Robert K Cleary; Shawn H Obi; Theodor Asgeirsson; Sarah K Evilsizer; Laurie G Fasbinder; Darrell A Campbell; Samantha K Hendren
Journal:  Dis Colon Rectum       Date:  2020-01       Impact factor: 4.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.